Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Long-Term Investments: 2020-2021

  • Tango Therapeutics' Long-Term Investments was N/A to $166.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $166.8 million, marking a year-over-year change of. This contributed to the annual value of $166.8 million for FY2020, which is N/A change from last year.
  • Tango Therapeutics' Long-Term Investments amounted to $166.8 million in Q2 2021, which was up 0.00% from $166.8 million recorded in Q1 2021.
  • In the past 5 years, Tango Therapeutics' Long-Term Investments ranged from a high of $166.8 million in Q4 2020 and a low of $166.8 million during Q3 2020.
  • In the last 2 years, Tango Therapeutics' Long-Term Investments had a median value of $166.8 million in 2021 and averaged $166.8 million.